SCHEMBL10115965

SCHEMBL10115965

Cc1ccc(N2C(=O)c3ccc(NC(=O)N4CCC(NS(=O)(=O)C(C)C)CC4)cc3C2=O)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.53
POLB P06746 3/20 0.53
HPGD P15428 1/20 0.53
LMNA P02545 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
CTDSP1 Q9GZU7 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
TSHR P16473 2/20 0.43
MAPK1 P28482 1/20 0.42
KMT2A Q03164 3/20 0.42
MEN1 O00255 1/20 0.42
ALOX15 P16050 1/20 0.42
EPHX2 P34913 1/20 0.41
TP53 P04637 2/20 0.40
MAPT P10636 2/20 0.40
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
CASP1 P29466 1/20 0.40
CASP7 P55210 1/20 0.40
HSD17B10 Q99714 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10115966 0.93 ALDH1A1 (0.43) ALDH1A1POLBHPGDLMNAMAPK1
SCHEMBL10115967 0.93 KMT2A (0.51) ALDH1A1POLBHPGDLMNACTDSP1
SCHEMBL10116176 0.90 EPHX2 (0.44) ALDH1A1POLBHPGDKMT2AMEN1
SCHEMBL10115934 0.87 ALDH1A1 (0.49) ALDH1A1POLBHPGDLMNANPSR1
SCHEMBL12882645 0.87 POLB (0.53) ALDH1A1POLBHPGDLMNANPSR1
SCHEMBL10115979 0.86 LMNA (0.40) ALDH1A1POLBHPGDLMNANPSR1
SCHEMBL10114807 0.86 ALDH1A1 (0.54) ALDH1A1POLBHPGDMAPK1KMT2A
SCHEMBL10115847 0.85 LMNA (0.59) POLBLMNANPSR1CTDSP1TDP1
SCHEMBL10115980 0.83 ALDH1A1 (0.58) ALDH1A1HPGDLMNANPSR1TDP1
SCHEMBL12882650 0.82 PANK3 (0.44) ALDH1A1POLBHPGDLMNANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8115027-B2 NPY Y5 antagonist SHIONOGI & CO., LTD. (JP) 2012-02-14 US disclosed
US-8115027-B2 NPY Y5 antagonist SHIONOGI & CO., LTD. (JP) 2012-02-14 US disclosed
US-20110039802-A1 NPY Y5 ANTAGONIST KAWANISHI YASUYUKI 2011-02-17 US disclosed
US-20100292500-A1 NPY Y5 ANTAGONIST KAWANISHI YASUYUKI 2010-11-18 US disclosed
US-20100292500-A1 NPY Y5 ANTAGONIST KAWANISHI YASUYUKI 2010-11-18 US disclosed
US-7781461-B2 NPY Y5 antagonist KAWANISHI YASUYUKI 2010-08-24 US disclosed
US-7781461-B2 NPY Y5 antagonist KAWANISHI YASUYUKI 2010-08-24 US disclosed
US-7265130-B2 NPY Y5 antagonist SHIONOGI & CO., LTD. (JP) 2007-09-04 US disclosed
US-7265130-B2 NPY Y5 antagonist SHIONOGI & CO., LTD. (JP) 2007-09-04 US disclosed
US-20070015762-A1 NPY Y5 antagonist KAWANISHI YASUYUKI 2007-01-18 US disclosed
US-20070015762-A1 NPY Y5 antagonist KAWANISHI YASUYUKI 2007-01-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070015762-A1 NPY Y5 antagonist NPY5R, NPY1R, NPY2R ALDH1A1 4558/4885POLB 4727/4885HPGD 3487/4885
US-20100292500-A1 NPY Y5 ANTAGONIST NPY5R, NPY1R, NPY2R ALDH1A1 4599/4885POLB 4751/4885HPGD 3475/4885
US-20110039802-A1 NPY Y5 ANTAGONIST NPY5R, NPY1R, NPY2R ALDH1A1 4517/4885POLB 4721/4885HPGD 3476/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.